Literature DB >> 26986627

Functional outcome at school age of neonatal post-hemorrhagic ventricular dilatation.

Janyte C Holwerda1, Koenraad N J A Van Braeckel2, Elise Roze2, Eelco W Hoving3, Carel G B Maathuis4, Oebele F Brouwer5, Albert Martijn6, Arend F Bos2.   

Abstract

BACKGROUND: Specific knowledge about the functional outcome of preterm born children with post-hemorrhagic ventricular dilatation (PHVD) is lacking.
OBJECTIVES: To determine functional outcome at school age in children with post-hemorrhagic ventricular dilatation and to identify whether PHVD characteristics increased the risk for deficits.
METHODS: Single-center case-control study. Included were preterm children born between 1996 and 2003 who had PHVD in their neonatal period. The controls were children matched for gestation, gender, and year of birth. At school age, using standardized tests and questionnaires, we assessed intelligence, attention, verbal memory, executive functioning, visual perception, visuomotor integration, motor skills, and behavior.
RESULTS: Of 34 children with PHVD 28 survived, three of whom could not be tested at school age (one child's parents declined and two were lost to follow-up). At a mean age of 10years (6-14years) the total and verbal IQs of the remaining 25 children (17 boys, 8 girls) were significantly lower compared to controls (difference in total IQ-14 points, verbal IQ-9 points, P=0.001and P=0.009, respectively). After adjustment for possible confounders, the performance of the PHVD group was poorer on visual perception and attention tests. Selective attention showed a trend toward risk of borderline and abnormal scores (OR 4.03, 95%-CI 0.84-19.2). Within the PHVD group, total IQ was significantly lower (P=0.048) in those who had undergone surgical intervention (n=12).
CONCLUSION: At school age, intelligence, attention, and visual perception were more affected in the PHVD group than in the matched controls. Surgical intervention was associated with lower IQ scores.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Hydrocephalus; Intervention; Neurodevelopmental outcome; Preterm infants

Mesh:

Year:  2016        PMID: 26986627     DOI: 10.1016/j.earlhumdev.2016.02.005

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  10 in total

1.  Preterm neonatal lateral ventricle volume from three-dimensional ultrasound is not strongly correlated to two-dimensional ultrasound measurements.

Authors:  Jessica Kishimoto; Sandrine de Ribaupierre; Fateme Salehi; Walter Romano; David S C Lee; Aaron Fenster
Journal:  J Med Imaging (Bellingham)       Date:  2016-11-09

Review 2.  Neurodevelopmental outcomes after ventriculoperitoneal shunt placement in children with non-infectious hydrocephalus: a meta-analysis.

Authors:  Mirna Sobana; Danny Halim; Jenifer Kiem Aviani; Uni Gamayani; Tri Hanggono Achmad
Journal:  Childs Nerv Syst       Date:  2021-01-21       Impact factor: 1.475

Review 3.  Preterm neuroimaging and neurodevelopmental outcome: a focus on intraventricular hemorrhage, post-hemorrhagic hydrocephalus, and associated brain injury.

Authors:  Rebecca A Dorner; Vera Joanna Burton; Marilee C Allen; Shenandoah Robinson; Bruno P Soares
Journal:  J Perinatol       Date:  2018-08-30       Impact factor: 2.521

4.  Early neurodevelopmental outcome in preterm posthemorrhagic ventricular dilatation and hydrocephalus: Neonatal ICU Network Neurobehavioral Scale and imaging predict 3-6-month motor quotients and Capute Scales.

Authors:  Rebecca A Dorner; Marilee C Allen; Shenandoah Robinson; Bruno P Soares; Jamie Perin; Ezequiel Ramos; Gwendolyn Gerner; Vera Joanna Burton
Journal:  J Neurosurg Pediatr       Date:  2019-12-20       Impact factor: 2.375

5.  Extended Combined Neonatal Treatment With Erythropoietin Plus Melatonin Prevents Posthemorrhagic Hydrocephalus of Prematurity in Rats.

Authors:  Shenandoah Robinson; Fatu S Conteh; Akosua Y Oppong; Tracylyn R Yellowhair; Jessie C Newville; Nagat El Demerdash; Christine L Shrock; Jessie R Maxwell; Stephen Jett; Frances J Northington; Lauren L Jantzie
Journal:  Front Cell Neurosci       Date:  2018-09-25       Impact factor: 5.505

6.  Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury.

Authors:  Sandra Horsch; Alessandro Parodi; Boubou Hallberg; Mariya Malova; Isabella M Björkman-Burtscher; Ingrid Hansen-Pupp; Neil Marlow; Kathryn Beardsall; David Dunger; Mirjam van Weissenbruch; Lois E H Smith; Mohamed Hamdani; Alexandra Mangili; Norman Barton; Luca A Ramenghi; Ann Hellström; David Ley
Journal:  Front Pediatr       Date:  2020-10-09       Impact factor: 3.418

7.  Caffeine Restores Neuronal Damage and Inflammatory Response in a Model of Intraventricular Hemorrhage of the Preterm Newborn.

Authors:  Pilar Alves-Martinez; Isabel Atienza-Navarro; Maria Vargas-Soria; Maria Jose Carranza-Naval; Carmen Infante-Garcia; Isabel Benavente-Fernandez; Angel Del Marco; Simon Lubian-Lopez; Monica Garcia-Alloza
Journal:  Front Cell Dev Biol       Date:  2022-08-12

8.  Functioning of the children with hydrocephalus.

Authors:  Lucyna Szefczyk-Polowczyk; Marek Mandera
Journal:  Acta Neurol Belg       Date:  2020-01-23       Impact factor: 2.396

Review 9.  Germinal Matrix-Intraventricular Hemorrhage of the Preterm Newborn and Preclinical Models: Inflammatory Considerations.

Authors:  Isabel Atienza-Navarro; Pilar Alves-Martinez; Simon Lubian-Lopez; Monica Garcia-Alloza
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

10.  Outcomes Following Post-Hemorrhagic Ventricular Dilatation among Infants of Extremely Low Gestational Age.

Authors:  Seetha Shankaran; Monika Bajaj; Girija Natarajan; Shampa Saha; Athina Pappas; Alexis S Davis; Susan R Hintz; Ira Adams-Chapman; Abhik Das; Edward F Bell; Barbara J Stoll; Michele C Walsh; Abbot R Laptook; Waldemar A Carlo; Krisa P Van Meurs; Pablo J Sánchez; M Bethany Ball; Ellen C Hale; Ruth Seabrook; Rosemary D Higgins
Journal:  J Pediatr       Date:  2020-07-30       Impact factor: 4.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.